After two doses all participants evaluated to date across the 25 µg and 100 µg dose cohorts seroconverted with binding antibody levels at or above levels seen in convalescent sera mRNA-1273 elicited ...

Add Yahoo as a preferred source to see more of our stories on Google. As SARS-CoV-2 has become endemic At IDWeek 2025, (the joint annual meeting of the Infectious Diseases Society of America, the ...

In a recent study published in the journal Pediatrics, researchers evaluated the effectiveness of primary BNT162b2, messenger ribonucleic acid (mRNA)-1273, and heterologous messenger ribonucleic acid ...

Moderna MRNA reported clinical data from its research assay, which confirmed that its updated COVID-19 vaccine mRNA-1273.815 generated an 8.7-fold increase in neutralizing antibodies against the ...

Current data reveals no significant differences in the antibody responses to the XBB.1 variant of SARS-CoV-2 between the BA.4/BA.5 and BA.1 vaccines. While the precise formulation of future vaccine ...

CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new ...

Although COVID-19 mRNA-1273 vaccination was associated with increased risk for anaphylaxis, myocarditis, and pericarditis, no other reported adverse events of special interest were considered related ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Boosting with a third dose of mRNA-1273 provided ...

In a recent study posted to the medRxiv preprint* server, researchers in the United States evaluated the immunogenicity and safety of messenger ribonucleic acid (mRNA) vaccines based on severe acute ...

In an observational study involving nearly 440,000 veterans, both the BNT162b2 vaccine and the mRNA-1273 vaccine were highly effective at preventing infection, hospitalization, and death from Covid-19 ...